Literature DB >> 5439684

Effect of postoperative empyema on survival of patients with bronchogenic carcinoma.

H Takita.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5439684

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  15 in total

1.  Common infections in the history of cancer patients and controls.

Authors:  U Abel; N Becker; R Angerer; R Frentzel-Beyme; M Kaufmann; P Schlag; S Wysocki; J Wahrendorf; G Schulz
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Tunneled pleural catheter use for pleural palliation does not increase infection rate in patients with treatment-related immunosuppression.

Authors:  Candice L Wilshire; Christopher R Gilbert; Brian E Louie; Ralph W Aye; Alexander S Farivar; Eric Vallières; Jed A Gorden
Journal:  Support Care Cancer       Date:  2017-11-29       Impact factor: 3.603

3.  Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.

Authors:  W Bakker; J M Nijhuis-Heddes; E A van der Velde
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung.

Authors:  F R Edwards; F Whitwell
Journal:  Thorax       Date:  1974-11       Impact factor: 9.139

5.  Postoperative empyema and survival in lung cancer.

Authors: 
Journal:  Br Med J       Date:  1973-03-03

6.  Influence of postoperative empyema on survival after pulmonary resection for bronchogenic carcinoma.

Authors:  H Minasian; C T Lewis; S J Evans
Journal:  Br Med J       Date:  1978-11-11

7.  Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis.

Authors:  M Markman
Journal:  West J Med       Date:  1985-07

8.  Prophylaxis of postpneumonectomy empyema.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

9.  Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.

Authors:  W Bakker; J M Nijhuis-Heddes; A M Wever; A Brutel de la Rivière; E A van der Velde; J H Dijkman
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

10.  Dr William Coley and tumour regression: a place in history or in the future.

Authors:  S A Hoption Cann; J P van Netten; C van Netten
Journal:  Postgrad Med J       Date:  2003-12       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.